Journal profile · Pediatrics
Pediatric Blood & Cancer
ISSN 1545-5009 · eISSN 1545-5017 · Wiley-Liss Inc. · UNITED STATES · Monthly · Founded 2004
Pediatric Blood & Cancer: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.34; hybrid open access; APC about USD 4,640; median 86 days to acceptance (131 articles, last 24 months); community-reported acceptance: about 25%; 751 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pediatric Blood & Cancer is published by Wiley-Liss Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Childhood Cancer Survivors' Quality of Life, Acute Lymphoblastic Leukemia research and Neuroblastoma Research and Treatments, together about 38.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy. Abstracting and Indexing Information Abstracts in Anthropology (Sage) Abstracts on Hygiene & Communicable Diseases (CABI) Agricultural & Environmental Science Database (ProQuest) Biological Abstracts (Clarivate Analytics) Biological Science Database (ProQuest) BIOSIS Previews (Clarivate Analytics) CAB Abstracts® (CABI) Current Contents: Clinical Medicine (Clarivate Analytics) Current Opinion in Pediatrics (Lippincott Williams & Wilkins) Embase (Elsevier) Global Health (CABI) Health & Medical Collection (ProQuest) Health Research Premium Collection (ProQuest) HEED: Health Economic Evaluations Database (Wiley-Blackwell) Helminthological Abstracts (CABI) Hospital Premium Collection (ProQuest) Journal Citation Reports/Science Edition (Clarivate Analytics) Leisure, Recreation & Tourism Abstracts (CABI) Materials Science & Engineering Database (ProQuest) MEDLINE/PubMed (NLM) Natural Science Collection (ProQuest) Nutrition Abstracts & Reviews Series A: Human & Experimental (CABI) Poultry Abstracts (CABI) ProQuest Central (ProQuest) Protozoological Abstracts (CABI) Review of Agricultural Entomology (CABI) Review of Aromatic & Medicinal Plants (CABI) Review of Medical & Veterinary Entomology (CABI) Review of Medical & Veterinary Mycology (CABI) Review of Plant Pathology (CABI) Rural Development Abstracts (CABI) Science Citation Index (Clarivate Analytics) Science Citation Index Expanded (Clarivate Analytics) SciTech Premium Collection (ProQuest) SIIC Databases (Sociedad Iberoamericana de Informacion Cientifica) Technology Collection (ProQuest) Tropical Diseases Bulletin (CABI) VINITI (All-Russian Institute of Science & Technological Information) Web of Science (Clarivate Analytics)
From the journal's Aims & Scope
Research area (LetPub): Pediatrics
Editor-in-chief Peter E. NewburgerPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 40, Canada 8, United Kingdom 4, Germany 4, Italy 3 (79 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Childhood Cancer Survivors' Quality of LifeMedicine16.7%
- Acute Lymphoblastic Leukemia researchMedicine14%
- Neuroblastoma Research and TreatmentsMedicine7.5%
- Hemoglobinopathies and Related DisordersMedicine5.7%
- Sarcoma Diagnosis and TreatmentMedicine5.3%
- Glioma Diagnosis and TreatmentMedicine5.1%
- Acute Myeloid Leukemia ResearchMedicine4.7%
- Hematopoietic Stem Cell TransplantationMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Pediatrics | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Pediatrics | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pediatrics | Zone 2 |
| Minor | Hematology | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.34LetPub ·
- Impact factor (publisher)
- 2.4Publisher website ·
- Impact factor (publisher) 2025
- 2.4Publisher website ·
- CiteScore 2026-06
- 3.9LetPub ·
- CiteScore (publisher)
- 3.9Publisher website ·
- CiteScore (publisher) 2025
- 3.9Publisher website ·
- SJR 2026-06
- 0.92LetPub ·
- SNIP 2026-06
- 1.06LetPub ·
- h-index
- 93LetPub ·
- h-index
- 147OpenAlex ·
- i10-index
- 6,110OpenAlex ·
- 2-year mean citedness
- 1.51OpenAlex ·
- Self-citation rate
- 12.5%LetPub ·
- Share of gold OA articles
- 36.12%LetPub ·
Volume
- Articles per year
- 476LetPub ·
- Articles per year (publisher) 2025
- 697Publisher website ·
- Downloads per year (publisher) 2025
- 1,441,579Publisher website ·
Articles by year OpenAlex count · 12,846 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 676 | 301 | 110 |
| 2025 | 751 | 416 | 1,080 |
| 2024 | 688 | 453 | 2,010 |
| 2023 | 680 | 433 | 3,750 |
| 2022 | 651 | 223 | 4,828 |
| 2021 | 708 | 274 | 7,860 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
86 daysMedian, submission to acceptance · P25–P75 40 days – 131 days
- Acceptance to online
- median 17 days (131 articles)
- Submission to online
- median 105 days
- Sample
- 131 articles with submission and acceptance dates (1,555 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1.5 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Acceptance rate (publisher)
- 34%Publisher website ·
- Acceptance rate (publisher) 2025
- 34%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to first decision 2025
- 5 daysPublisher website ·
- Submission to acceptance 2025
- 76 daysPublisher website ·
- Acceptance to publication 2025
- 17 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,640 / EUR 3,860 / GBP 3,040 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Reference style
- Chicago
Article types accepted12
- brief reportSubmission Type Description Abstract Word count** References Maximum # of Primary Figures and Tables*** (Combined) Research Articles Articles should represent o…Length not stated
- brief reportsBrief reports may include descriptions of single or several patients that demonstrate novel findings or add in a significant way to current knowledge.Length not stated
- case reportSubmission Type Description Abstract Word count** References Maximum # of Primary Figures and Tables*** (Combined) Research Articles Articles should represent o…Length not stated
- critical reviewsCritical Reviews Reviews of important and timely subjects can be invited through the Editorial Board or submitted after a brief introduction to the Editor-in-Ch…Length not stated
- editorialSubmission Type Description Abstract Word count** References Maximum # of Primary Figures and Tables*** (Combined) Research Articles Articles should represent o…Length not stated
- how i approachHow I Approach These articles may be submitted only at the invitation of the Editors.Length not stated
- letters to the editorSubmission Type Description Abstract Word count** References Maximum # of Primary Figures and Tables*** (Combined) Research Articles Articles should represent o…Length not stated
- meta-analysisSubmission Type Description Abstract Word count** References Maximum # of Primary Figures and Tables*** (Combined) Research Articles Articles should represent o…Length not stated
- research articleSubmission Type Description Abstract Word count** References Maximum # of Primary Figures and Tables*** (Combined) Research Articles Articles should represent o…Length not stated
- research articlesResearch Articles Articles should represent original and in-depth studies involving any aspect of clinical or laboratory investigation.Length not stated
- reviewSubmission Type Description Abstract Word count** References Maximum # of Primary Figures and Tables*** (Combined) Research Articles Articles should represent o…Length not stated
- systematic reviewSubmission Type Description Abstract Word count** References Maximum # of Primary Figures and Tables*** (Combined) Research Articles Articles should represent o…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, License & copyright, Trial registration / reporting guidelines
- Authorship
No page charges for publication. Model summary
No page charges will be levied against authors or their institutions for publication in this journal.
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Expects data sharing; authors should archive data in a public repository. Model summary
Please review Wiley’s policy here. This journal expects data sharing.
Source ↗Publisher website ·- License & copyright
Copyright transfer to publisher upon submission. Model summary
Upon submission of a manuscript for publication, the author will be requested to sign an agreement transferring copyright to the publisher, who reserves copyright.
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of:
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Liss Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 2004
- ISSN
- 1545-5009
- Electronic ISSN
- 1545-5017
- Latest issue on the website
- Volume 73, Issue 10 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pediatric Blood & Cancer
What CAS zone is Pediatric Blood & Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pediatric Blood & Cancer is in Zone 3 of Medicine, and in Zone 3 of the minor category Hematology / Pediatrics / Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pediatric Blood & Cancer?
The latest impact factor listed by LetPub is 2.34; CiteScore 3.9, h-index 147.
How long does peer review take at Pediatric Blood & Cancer?
Based on the dates recorded on 131 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 86 days (interquartile range 40–131 days); authors report an average review time of about 1.5 months; the community-reported acceptance is “about 25%”; the journal's website gives an acceptance rate of 34% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Pediatric Blood & Cancer based?
Of the 79 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (40), Canada (8) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Pediatric Blood & Cancer?
According to LetPub and DOAJ records, Pediatric Blood & Cancer is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Pediatric Blood & Cancer open access, and what is the APC?
Pediatric Blood & Cancer is a hybrid journal. For open-access publication: APC about USD 4,640.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .